# Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

> **NCT06596291** · PHASE1,PHASE2 · RECRUITING · sponsor: **EG 427** · enrollment: 16 (estimated)

## Conditions studied

- Neurogenic Detrusor Overactivity
- Spinal Cord Injuries

## Interventions

- **DRUG:** EG110A

## Key facts

- **NCT ID:** NCT06596291
- **Lead sponsor:** EG 427
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-08
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06596291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06596291, "Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06596291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*